Clinical trials: Prognostic Factors
Hepatocellular Carcinoma
The Clinicopathological and Prognostic Factors of Hepatocellular Carcinoma; 10 Years' Tertiary Center Experience in Egypt
This study aimed at study the clinical and pathological criteria of Hepatocellular carcinoma to keep with new challenging in diagnosis and morpho-molecular classifications
- Trial name
- NCT05047146
- Testing
- Morphological classifications of HCC
- Where
- Egypt
- Volunteers
- 530 people
- Sponsor
- Sadat City University
Researcher-Subject Relations
Prognostic Factors for Visual Improvement in Patients Undergoing Intravitreal Ranibizumab for Retinal Vein Occlusion
Primary Objective: To investigate the pretreatment quantitative factors as shown in SD-OCT images that correlate with posttreatment VA in patients who underwent intravitreal Lucentis (Ranibizumab) for RVO.
- Trial name
- NCT02144662
- Testing
- Ranibizumab
- Volunteers
- 50 people
- Sponsor
- St. Marianna University School of Medicine
SARS CoV 2 Infection, Alveolar; Injury
The Potential Role of sRAGE, KL-6, and SP-D as Prognostic Factors in Children With COVID-19
COVID-19 causes a wide spectrum of clinical illness, from upper respiratory symptoms to severe respiratory failure and death. Several plasma biomarkers -such as IL-6, C-reactive protein (CRP), D-dimer, the…
- Conditions
- SARS CoV 2 Infection, Alveolar; Injury, Children, Pneumonia, Viral
- Trial name
- NCT05619640
- Where
- Turkey (Türkiye)
- Volunteers
- 150 people, healthy volunteers welcome
- Sponsor
- Haseki Training and Research Hospital
Healthy Volunteers, Children With HSP
Polymorphism of the IgH Locus Regulatory Region as a Prognostic Factor During Immune Pathologies.
The investigators previously showed that both antibody class switching (from IgM to IgG, IgA or IgE) and antibody secretion are controlled by a polymorphic "3' regulatory region" (3'RR) of the immunoglobulin heavy chain (IgH)…
- Conditions
- Healthy Volunteers, Children With HSP, Subject With Allergy, Lymphoma
- Trial name
- PRIERR (NCT01715623)
- Testing
- a blood sample
- Where
- 4 sites in France
- Volunteers
- 486 people, healthy volunteers welcome
- Sponsor
- University Hospital, Limoges
Carbon Monoxide Poisoning, Myocardial Injury
CARbon monoxidE intoxiCatiOn in Korea: Prospective Cohort (CARE CO Cohort)
This prospective cohort study enrolls subjects who experience carbon monoxide (CO) poisoning. The purpose of the study is to evaluate therapeutic effects of various treatments and short and long-term outcomes in CO poisoned…
- Conditions
- Carbon Monoxide Poisoning, Myocardial Injury, Neurologic Deficits, Image, Body
- Trial name
- NCT04490317
- Testing
- Cardiac MRI, Hyperbaric oxygen therapy
- Where
- South Korea
- Volunteers
- 1,500 people
- Sponsor
- Wonju Severance Christian Hospital
Coma, Carbon Monoxide Poisoning
Carbon Monoxide-induced Coma: Prognostic Factors
The primary objective of the study is to determine prognostic factors for hospital-mortality following carbon monoxide (CO)-induced coma.
- Trial name
- Coma-CO (NCT03926494)
- Where
- France
- Volunteers
- 212 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Coronary Artery Disease
Ultra-low-dose CACS in a Large Population
Radiation exposure to patients from CT for CAC scoring has steadily decreased in recent years. This is mainly achieved through lowering tube currents alongside with the introduction of iterative reconstruction algorithms which…
- Trial name
- ULDCACSLARGE (NCT03637231)
- Testing
- Ultra low-dose CTAC
- Where
- Switzerland
- Volunteers
- 301 people
- Sponsor
- University of Zurich
Isolated Noncompaction of the Ventricular Myocardium
Risk Stratification and Early Prevention Strategies for Non-compaction of Ventricular Myocardium (CAPTAIN)
This study intends to retrospectively-prospectively enroll NVM patients from multiple centers to establish a natural population cohort of NVM patients.
- Trial name
- NCT06504056
- Testing
- Diagnosis of NVM
- Where
- China
- Volunteers
- 2,000 people
- Sponsor
- First Affiliated Hospital Xi'an Jiaotong University
Leukemia, Lymphoma
Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia
RATIONALE: Collecting and storing samples of tumor tissue, blood, bone marrow, and other body fluids from patients to test in the laboratory and collecting information about the patient's health and treatment may help doctors…
- Trial name
- NCT01185886
- Testing
- gene expression analysis, mutation analysis, polymorphism analysis
- Where
- 21 sites in Belgium, France and 1 more
- Volunteers
- 1,200 people
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
NSCLC Stage IV
Factors Determining the Prognosis in NSCLC Stage IV
This study is a cohort study with patients with advanced NSCLC. Patients will answer questionnaires about symptoms and quality of life and will be submitted to physical and blood tests, and computer tomography.
- Trial name
- LUPROG (NCT04306094)
- Where
- Brazil
- Volunteers
- 217 people
- Sponsor
- Instituto do Cancer do Estado de São Paulo
Neuroendocrine Tumors, Carcinoma;Endocrine
Multicenter Retrospective Database on Prognostic and Predictive Factors in Patients With Neuroendocrine Tumors
Multicenter retrospective longitudinal analytical study of patients with neuroendocrine tumors.
- Trial name
- NET (NCT05168631)
- Where
- 8 sites in Argentina, Brazil and 2 more
- Volunteers
- 88 people
- Sponsor
- Latin American Cooperative Oncology Group
Cardiac Surgery
Study of Prognostic Factors in Interventional Rhythmology
Develop a prospective register assessing the short- and long-term complications of patients undergoing interventional rhythm
- Trial name
- PRINT (NCT03099057)
- Testing
- follow-up of patients after interventional rhythm operation
- Where
- France
- Volunteers
- 2,805 people
- Sponsor
- University Hospital, Brest
Metastatic NSCLC - Non-Small Cell Lung Cancer
Large Granular Lymphocytes in mNSCLC Treated With Nivolumab
Large granular lymphocytes (LGLs), which constitute 10-15% of peripheral blood mononuclear cells, are large lymphocytes with a round nucleus, large cytoplasm, and azurophilic granules in the cytoplasm.
- Trial name
- NCT07363811
- Where
- Turkey (Türkiye)
- Volunteers
- 50 people
- Sponsor
- Necmettin Erbakan University
Cerebral Arteriovenous Malformation, Intracranial Arterial Diseases
Cerebral Arteriovenous Malformation With Aneurysm: Epidemiology, Clinical Features, and Prognosis
The study is a multicenter, prospective cohort study designed to assess the natural history, clinical safety and efficacy of various treatment strategies in patients with cerebral arteriovenous malformations (AVMs) and…
- Conditions
- Cerebral Arteriovenous Malformation, Intracranial Arterial Diseases, Intra Cerebral Hemorrhage, Intracranial Aneurysm
- Trial name
- NCT07353736
- Where
- China
- Volunteers
- 630 people
- Sponsor
- Duan Chuanzhi
Pancreatic Cancer
Evaluation of Survival Prognostic Factors for Patients With Exocrine Pancreatic Cancer Resectable or Potentially Resectable
This study aims to collect clinical, biological and quality of life data from patients with a borderline or resectable pancreatic cancer.
- Trial name
- Pancreas-CGE (NCT02818907)
- Testing
- Additional biological samples
- Where
- 8 sites in France
- Volunteers
- 290 people
- Sponsor
- Centre Hospitalier Universitaire de Besancon
Interstitial Lung Disease
Risk Factors and Prognostic Parameters of Interstitial Lung Disease in Children
Study the severity and outcome of children with interstitial lung disease
- Trial name
- NCT06125288
- Testing
- lab investigation and radiation
- Volunteers
- 25 people
- Sponsor
- Assiut University
Liver Transplant; Complications
Proteinuria in Liver Transplantation, a Single Egyptian Center Study
Proteinuria has been suggested to be a predictive factor and an important tool for differentiating the etiology of renal dysfunction in various clinical scenarios .The good predictive performance of preoperative proteinuria…
- Trial name
- NCT05733754
- Where
- Egypt
- Volunteers
- 70 people
- Sponsor
- Assiut University
Breast Cancer
PiA: Prognosis Used Every Day for Patients With Operable Breast Cancer - Comparison of Invasion Factors uPA/PAI-1 With Other Prognostic Factors
The improvement of the healing rates for breast cancer is based to an important part on the consistent use of so-called adjuvant ("supporting ") medicamentous therapies, including chemotherapy.
- Trial name
- PiA (NCT01592825)
- Volunteers
- 1,000 people
- Sponsor
- Martin-Luther-Universität Halle-Wittenberg
Lymphoma, Peripheral Neuropathy
Chemotherapy Induced Peripheral Neuropathy (CIPN) and Lymphoma Longitudinal Follow-up and Prognostic Factors
Vincristine-induced peripheral neuropathy, which is commonly a sensorimotor neuropathy, remains a major complication of lymphoma patients treated with R-CHOP.
- Trial name
- NeuroTox-L (NCT05378256)
- Testing
- Clinical scales of CIPN
- Where
- France
- Volunteers
- 40 people
- Sponsor
- Centre Hospitalier Régional d'Orléans
Radiotherapy, Immune Checkpoint Inhibitors (ICIs)
Real-world Study on the Efficacy, Safety, and Prognostic Factors of Immune Checkpoint Inhibitors Combined With Radiotherapy in Patients With Malignant Tumors: A Prospective Non-interventional Clinical Study
Currently, chemotherapy, targeted therapy, immunotherapy, and radiotherapy are the core treatment modalities for malignant tumors, with technologies advancing rapidly.
- Trial name
- NCT07665736
- Where
- China
- Volunteers
- 200 people
- Sponsor
- Sichuan University